Skip to main content

Day: March 29, 2022

Monte Rosa Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Business Updates

– Company on Track for Mid-year Filing of Investigational New Drug (IND) Application for Lead Candidate MRT-2359 – – Progressed NEK7 and CDK2 Molecular Glue Degrader Programs into Lead Optimization – – Year-end Cash and Cash Equivalents Expected to Provide Runway into Late 2024 – BOSTON, March 29, 2022 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a biotechnology company developing novel molecular glue degrader (MGD) medicines, today reported business highlights and financial results for the fourth quarter and full year, ended December 31, 2021. “Last year was transformational for Monte Rosa as we continued to build out our world-class leadership team, expanded operations across our two sites in Boston and Basel, named MRT-2359 our development candidate for the GSPT1 program, and secured $377.6 million in funding,”...

Continue reading

Dycom Industries, Inc. Appoints Carmen M. Sabater As Director

PALM BEACH GARDENS, Fla., March 29, 2022 (GLOBE NEWSWIRE) — Dycom Industries, Inc. (NYSE: DY) today announced the appointment of Carmen M. Sabater as a director. Ms. Sabater is a Certified Public Accountant and currently serves as the Chief Financial Officer of Quirch Foods Parent, LLC (“Quirch”), a national food distribution company with a portfolio of owned brands. She has served in that role since February 2002 and has led Quirch’s integration strategy and also has experience with both human capital and technology functions. Prior to that, Ms. Sabater was the Controller of MasTec, Inc. from 1994 to 2000 and was then appointed as its Chief Financial Officer, serving in that role until January 2002. Ms. Sabater was previously at Deloitte & Touche, LLP, as an auditor and then as a Senior Manager from 1985 to 1994. She...

Continue reading

Teledyne Princeton Instruments announces new series of CCD cameras for Original Equipment Manufacturers

The LANSIS CCD cameras extend Teledyne’s spectroscopy portfolio into system integrator and OEM marketsLANSIS CCD Camera LANSIS spectroscopy cameras for OEM applicationsTRENTON, N.J., March 29, 2022 (GLOBE NEWSWIRE) — Teledyne Princeton Instruments, a Teledyne Technologies [NYSE: TDY] company, announces the release of LANSIS—a new spectroscopy detector designed specifically for original equipment manufacturers (OEM) and system integrators. LANSIS cameras represent the latest in CCD array detector technology specifically tailored to OEMs. Michael Case, product manager at Teledyne Princeton Instruments notes, “LANSIS camera development was driven by OEM requirements, and is designed to offer the highest reliability, performance, sensitivity, for easy integration into OEM platforms; and with competitive OEM pricing.” LANSIS is...

Continue reading

Gb Sciences’ Nanoparticle Encapsulation Technology Improves the Efficacy of Terpenes for Use in Our Chronic Pain Formulations as Demonstrated in New Research Article

On March 25, the University of Seville, Chaminade University, and Gb Sciences co-published the results from Gb Sciences-sponsored study in the International Journal of Pharmaceutics. Gb Sciences’ proprietary, time-released, oral nanoparticle technology improved the efficacy of cannabis-based terpenes in modulating a known pain receptor in this study.Featured Image for Gb Sciences Featured Image for Gb SciencesLAS VEGAS, March 29, 2022 (GLOBE NEWSWIRE) — Gb Sciences, Inc. (OTCQB:GBLX), a leading cannabis- and plant-inspired, biopharmaceutical research and development company, announces that their sponsored study investigating the effect of nanoparticle encapsulation of three cannabis-based terpenes on their potential efficacy in pain management was published in the International Journal of Pharmaceutics on March 25. For...

Continue reading

General Motors Names Gentex a 2021 Supplier of the Year

GM 2021 Supplier of the Year Award Gentex Corporation was recently recognized by General Motors as a 2021 Supplier of the Year.ZEELAND, Mich., March 29, 2022 (GLOBE NEWSWIRE) — Gentex Corporation (NASDAQ:GNTX) was recently recognized by General Motors as a 2021 Supplier of the Year during GM’s 30th annual Supplier of the Year awards ceremony in Phoenix, Arizona. GM’s Supplier of the Year award recognizes global suppliers that distinguish themselves by exceeding GM’s requirements – in turn providing GM customers with innovative technologies — and are among the highest quality in the automotive industry. This year, GM recognized 134 suppliers from 16 countries with the Supplier of the Year distinction. Gentex is a leading supplier of digital vision, connected car, and dimmable glass technologies for the global automotive industry....

Continue reading

Suominen launches BIOLACE® Zero, its first carbon neutral nonwoven

Suominen Corporation’s press release on March 29, 2022 at 3:00 p.m. EEST Suominen launches a carbon neutral nonwoven, BIOLACE® Zero. BIOLACE® Zero is an excellent product for many kinds of wiping applications like baby, personal care, and household wipes. It has excellent wet and dry strength and it’s very soft. It is made of 100% cellulosic lyocell fibers and the product is 100% biodegradable, compostable and plastic free. BIOLACE® Zero utilizes VEOCEL™ Lyocell fibers from Suominen´s long-term partner Lenzing. BIOLACE® Zero is made of 100% carbon neutral VEOCEL™ Lyocell fibers. “We are very excited to introduce BIOLACE® Zero, which is not just Suominen´s first carbon neutral product, but also one of the first carbon neutral nonwovens on the market. BIOLACE® Zero will be available as part of Suominen’s sustainable product portfolio”,...

Continue reading

The first instalment of the proposed quarterly cash dividend of USD 0.5625 per share will amount to SEK 5.30 per share

Lundin Energy AB (Lundin Energy) announces that the first instalment of the proposed quarterly cash dividend of USD 0.5625 per share will amount to SEK 5.30 per share, with a total amount of MSEK 1,508, corresponding to approximately MUSD 160. The proposed quarterly cash dividend remains subject to approval by the 2022 Annual General Meeting (AGM) that will be held on 31 March 2022. Information about the first instalment of the proposed quarterly cash dividend:Amount per share(SEK) Total dividend amount (MSEK) Ex-dividend date Record date Expected payment date5.30 1,508 1 April 2022 4 April 2022 7 April 2022The Board of Directors has proposed to the 2022 AGM a quarterly cash dividend for 2021 of USD 0.5625 per share, corresponding to MUSD 160 (rounded off) per quarter. According to the proposal, before payment, each quarterly...

Continue reading

MediWound to Present EscharEx Clinical Data at the Symposium on Advanced Wound Care (SAWC) Spring 2022

Results Highlight the Safety and Efficacy in Hard-to-Heal Wounds SAWC to Take Place in Phoenix, Arizona on April 6-10, 2022 YAVNE, Israel, March 29, 2022 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration, today announced a poster and oral presentation of its EscharEx® clinical data at the 35th Symposium on Advanced Wound Care (SAWC) Spring Conference taking place in Phoenix, Arizona on April 6-10, 2022 (Home | SAWC Spring). The oral presentation, titled: “Introduction to EscharEx: An Innovative Enzymatic Solution for the Debridement of Hard to Heal Wounds,” will be moderated by Vickie R. Driver, DPM, MS, FACFAS FAAWC (University of Virginia and Inova Healthcare) and will feature, John C. Lantis, M.D....

Continue reading

Grove Inc. Completes Initial Transactions in Program to Repurchase Up to 1 Million Shares

HENDERSON, NV, March 29, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Grove, Inc. (NASDAQ:GRVI) (“Grove” or the “Company”),Grove Inc., today announced that it has completed the first stage of its previously authorized program to repurchase up to 1 million shares of its outstanding common stock through both the use of the Company’s 10b5-1 plan and privately negotiated transactions.  The Company repurchased 467,765 shares at an average cost of approximately $4.22 per common share or $1,974,896. These repurchases were made as part of the company’s repurchase program, which was announced on October 19, 2021. Grove will continue to review the authorized program and may repurchase up to an additional 500,000 shares.  “Grove continues to generate strong revenue growth, positive cash flow from operations...

Continue reading

FuelPositive Announces Key Market Research Appointments

Fully understanding the customer’s reality will guide decision-making as FuelPositive prepares for commercialization TORONTO, March 29, 2022 (GLOBE NEWSWIRE) — FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) (“FuelPositive” or the “Company”) is pleased to announce two key appointments focused on fully understanding its customers as it nears market entry. Pollara Strategic Insights has been appointed FuelPositive’s market research partner. As well, Leith Deacon, an Associate Professor and researcher from the University of Guelph, has been appointed as an Advisor, helping to guide the Company’s market research efforts. “We have identified the farming community in Canada as our first customer for our on-site green ammonia production system. That means we need to learn everything we can about farmers. We already know they are...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.